BioMarin Pharmaceutical competitors

BioMarin Pharmaceutical's competitors include Mylan, MyoKardia, Athersys and Ironwood Pharmaceuticals
Add company...
BioMarin Pharmaceutical
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Mylan
Mylan offers generic and specialty pharmaceutical products.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Founding Date
Founding Date
1997
Founding Date
1961
Founding Date
2012
Founding Date
1995
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Rafael, US HQ
Pilar, AR
Buenos Aires, AR
Brisbane, AU
Sydney, AU
São Paulo, BR
Mocoa, CO
see more
Locations
Canonsburg, US HQ
Hertfordshire, GB
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Cambridge, US HQ
Employees
Employees
2,293
Employees
35,000
Employees
1024% increase
Employees
60
Employees
674
Valuation ($)
Valuation ($)
15.9 b
Valuation ($)
20.4 b
Valuation ($)
1.8 b
Valuation ($)
321.4 m
Valuation ($)
2.8 b
Facebook likes
Facebook likes
186
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
475
Facebook likes
18
Twitter followers
Twitter followers
N/A
Twitter followers
7.2 k
Twitter followers
387
Twitter followers
953
Twitter followers
3.1 k

Financial

Revenue (est.)
Revenue (est.)
$1.1b (FY, 2016)
Revenue (est.)
$7.6b (FY, 2014)
Revenue (est.)
$22.5m (FY, 2017)
Revenue (est.)
$3.7m (FY, 2017)
Revenue (est.)
$274m (FY, 2016)
Cost of goods
Cost of goods
$209.6m (FY, 2016)
Cost of goods
$4.2b (FY, 2014)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$907.2m (FY, 2016)
Gross profit
$3.5b (FY, 2014)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($630.2m) (FY, 2016)
Net income
$933.1m (FY, 2014)
Net income
($46m) (FY, 2017)
Net income
N/A
Net income
($81.7m) (FY, 2016)

Operating

Patent Applications
Patent Applications
426 (FY, 2016)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
170 (FY, 2016)
Patent Applications
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents Issued
Patents Issued
1.2 k (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 9m
Total funding raised
$ 284m
For sources of this data, please see the company profileDownload Excel

View company profiles

Mylan
HQ
Canonsburg, US
Employees
35,000

Mylan offers generic and specialty pharmaceutical products.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
60

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
674

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company